NOVONIX Ltd Files Routine 6-K Report
Ticker: NVNXF · Form: 6-K · Filed: Aug 19, 2025 · CIK: 1859795
Sentiment: neutral
Topics: sec-filing, 6-k, reporting
Related Tickers: NVX
TL;DR
NOVONIX filed a standard 6-K, no major news, just routine reporting.
AI Summary
NOVONIX Limited, a foreign private issuer, filed a Form 6-K on August 19, 2025, reporting for the month of August 2025. The company, incorporated in Australia with its principal executive office in Brisbane, QLD, is required to file annual reports under Form 20-F. The filing does not contain specific financial figures or operational updates beyond its routine reporting status.
Why It Matters
This filing indicates NOVONIX is meeting its SEC reporting obligations as a foreign private issuer. Investors can monitor these filings for any material updates.
Risk Assessment
Risk Level: low — This is a routine SEC filing (Form 6-K) and does not contain new material information or financial disclosures.
Key Players & Entities
- NOVONIX Limited (company) — Registrant
- 0000950170-25-109902 (filing_id) — Accession Number
- 20250819 (date) — Filing Date
- Brisbane, QLD (location) — Principal Executive Office
FAQ
What is the purpose of a Form 6-K filing?
A Form 6-K is a report of foreign private issuers required to be filed with the SEC pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934, typically for reporting information made public in their home country.
Which form does NOVONIX Limited use for its annual reports?
NOVONIX Limited files its annual reports under cover of Form 20-F.
Where is NOVONIX Limited's principal executive office located?
NOVONIX Limited's principal executive office is located at Level 38, 71 Eagle Street, Brisbane, QLD 4000, Australia.
What is the filing date of this specific Form 6-K?
The filing date (Conformed Submission Date) for this Form 6-K is August 19, 2025.
Does this filing contain specific financial results for the period?
No, this Form 6-K filing does not appear to contain specific financial results or operational updates; it serves as a routine report for the month of August 2025.
Filing Stats: 203 words · 1 min read · ~1 pages · Grade level 14.2 · Accepted 2025-08-18 20:10:51
Key Financial Figures
- $5 Million — ment (NOVONIX Selected to Receive up to $5 Million in Non-Dilutive Funding from Natural Re
Filing Documents
- nvx-6k-jul-25-08-19_nrca.htm (6-K) — 26KB
- nvx-ex99_1.htm (EX-99.1) — 28KB
- img58969013_0.jpg (GRAPHIC) — 41KB
- 0000950170-25-109902.txt ( ) — 112KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. NOVONIX LIMITED By: /s/ Robert Long Robert Long Chief Financial Officer Date: August 19, 2025